What does INNOVACE do?

INNOVACE is a specialist medical practice in Ukkel. Private Limited, started on 13 November 2023, 1 establishment.

What is the address of INNOVACE?

The registered office of INNOVACE is located at Sterstraat 11 box 9, 1180 Ukkel.

Is INNOVACE still active?

Yes. According to the CBE (31 October 2026) INNOVACE is active, legal situation “Normale toestand”, started on 13 November 2023.

Is INNOVACE registered on Peppol?

Yes, INNOVACE is registered on the Peppol network with ID 0208:1002203604.

What is the enterprise number of INNOVACE?

The enterprise number of INNOVACE is BE1002203604.

When was INNOVACE founded?

INNOVACE was founded on 13 November 2023.

Who are the directors of INNOVACE?

According to the 2025 annual accounts, the directors of INNOVACE are: Edward KAHHALEH.

Is INNOVACE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 November 2023; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did INNOVACE make in 2025?

INNOVACE posted a profit after taxes of € 209,192 in financial year 2025.

What is the revenue of INNOVACE?

As a small company, INNOVACE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 284,583.

INNOVACE (Private Limited) - Ukkel - BE1002203604

Dossier INNOVACE, printed on 31 October 2026 from databakkes.be/en/1002203604/innovace. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

INNOVACE from Ukkel, company number BE1002203604, closed financial year 2025 with a result of € 209,192 after tax. For that financial year INNOVACE recorded a gross margin of € 284,583 and equity of € 350,154. Compared with financial year 2024, the result moved from € 138,962 to € 209,192. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 350,154

▲ 148% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 209,192

▲ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 201,703

▲ 288% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 348,154.

People and assets in 2025

Vehicles and equipment

€ 1,234

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 171,151

€ 25,699 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 4,235

▲ € 3,950 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,660

▼ 18% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 189,661 Gross margin 2024: € 189,661 First fiscal year in the series	€ 284,583 Gross margin 2025: € 284,583 ▲ 50% vs 2024 (€ 189,661) Favourable step	▲ 50%
Profit after taxes	€ 138,962 Profit after taxes 2024: € 138,962 First fiscal year in the series	€ 209,192 Profit after taxes 2025: € 209,192 ▲ 51% vs 2024 (€ 138,962) Favourable step	▲ 51%
Equity	€ 140,962 Equity 2024: € 140,962 First fiscal year in the series	€ 350,154 Equity 2025: € 350,154 ▲ 148% vs 2024 (€ 140,962) Favourable step	▲ 148%
Total debts	€ 8,818 Total debts 2024: € 8,818 First fiscal year in the series	€ 182,046 Total debts 2025: € 182,046 ▲ € 173,228 vs 2024 (€ 8,818) Unfavourable step	▲ € 173,228
Cash	€ 52,007 Cash 2024: € 52,007 First fiscal year in the series	€ 201,703 Cash 2025: € 201,703 ▲ 288% vs 2024 (€ 52,007) Favourable step	▲ 288%
Retained profit	€ 138,962 Retained profit 2024: € 138,962 First fiscal year in the series	€ 348,154 Retained profit 2025: € 348,154 ▲ 151% vs 2024 (€ 138,962) Favourable step	▲ 151%
Bank debt	€ 0 Bank debt 2024: € 0 First fiscal year in the series	€ 171,151 Bank debt 2025: € 171,151 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 149,780 Balance sheet total 2024: € 149,780 First fiscal year in the series	€ 532,200 Balance sheet total 2025: € 532,200 ▲ 255% vs 2024 (€ 149,780) Unchanged	▲ 255%

Key figures of INNOVACE, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to INNOVACE?

What happened at INNOVACE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 209,192 (▲ 51% vs 2024). Source: NBB ↗
Nov 13, 2023 New establishment in Ukkel. KBO
2023 Edward KAHHALEH became a director. NBB
Nov 13, 2023 Start of the company according to the CBE. KBO

In short

From € 138,962 profit in 2024 to € 209,192 profit in 2025.

Paid € 119,750 in corporate taxes since 2024.

Best year ever: 2025, with € 209,192 profit.

Original PDFs at the National Bank ↗

Management

Edward KAHHALEH

INNOVACE

KRAAINEM33 20%

FOOT AND ANKLE INSTITUE 14.3%

Behind INNOVACE is Edward KAHHALEH. It owns 20% of KRAAINEM33 and 14.3% of FOOT AND ANKLE INSTITUE itself.

Directors

According to the 2025 annual accounts

Edward KAHHALEH

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Sterstraat 11 box 9

1180 Ukkel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

YARED MEDICAL

€ 190,614 gross margin · 2025

LEH Dental

€ 7,190 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1002.203.604
VAT number: BE 1002.203.604
Registered office: Sterstraat 11 bus 9, 1180 Ukkel
Names & denominations: INNOVACE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 November 2023
Peppol: Active · Active since 26 Jan 2026
Contact: [email protected]
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗